Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Thyroid Multidisciplinary Team Meeting – 4 July 2012 Name: DOB: MRN: Consultant: Diagnosis Reason for Review Is input from Medical Oncologist required? INITIAL PRESENTATION Presentation Risk factors: XRT FHx SHx Initial U/S Initial FNA SURGICAL MANAGEMENT Date: Surgeon: Yes / No Comorbidities: Procedure: Finding: HISTOLOGY Type Max diam Lymph nodes Invasion RADIOIODINE REMNANT ABLATION Date Dose Post-treatment scan result Stimulation Tg TgAb TSH FOLLOW UP Date Event (Ix/Rx) Stimulation Tg TgAb TSH Result SUMMARY & RECOMMENDATIONS Summary: Recommendation: Further Instructions for Data Collection FNA needs to say which side or nodule was sampled every time Measurements should all be in mm, not cm RAI should be reported in mCi, not Mbq Method of stimulation can be abbreviated as T4WD or rh-TSH for T4 withdrawal or human recombinant TSH, respectively PLEASE USE THE FOLLOWING STANDARD ABBREVIATONS Stim Tg stimulated thyroglobulin Unstim Tg unstimulated thyroglobulin TgAb thyroglobulin antibody T4wd thyroid hormone withdrawal RhTSH recombinant human TSH (thyrogen) DxWBS diagnostic (low dose) radioiodine whole body scan TxWBS post-treatment (high dose) radioiodine whole body scan PTC papillary thyroid cancer PTCfv papillary thyroid cancer, follicular variant FTC follicular thyroid cancer MTC medullary thyroid cancer CLND central lymph node dissection CURRENT TNM STAGING (AJCC 6th ed) T1 <2cm T2 2-4cm T3 >4cm or minimal extratrathyroidal invasion T4a gross extathyroidal invasion T4b into prevertebral fascia, encasing carotid or medst vessels N1a N1b level VI nodes any other nodes Stage <45yo I M0 II M1 III IVa IVb >45yo T1, N0 T2, N0 T3, N0 T1-3, N1a T1-3, N1b T4a, any N T4b, any N IVc M1